WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 ...

WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 ...

GALWAY, Ireland, May 10, 2026 (GLOBE NEWSWIRE) -- WhiteSwell, a clinical-stage medtech company pioneering a new treatment paradigm for acute decompensated heart failure (ADHF), today announced primary results from the DELTA-HF feasibility clinical trial evaluating the eLym System for ADHF.…

WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure

Six-month clinical data from 40 patients highlights safety, effective decongestion, stable renal function, and reduced

WhiteSwell’s heart failure device promising but patient death rattles results

Despite a patient death, WhiteSwell is moving forward with its plans to conduct the randomised LYMPH-HF trial on its eLym system in ADHF.The post WhiteSwell’s heart failure device promising but patient death rattles results appeared first on Medical Device Network.